We are currently updating the website to provide enhanced features as part of RCNi Plus. If you come across any unusual functionality during this period or have feedback about the changes to the website, please contact customer services
Journal scan

Rapid diagnosis, treatment crucial to melanoma survival

Fast diagnosis and treatment of melanoma can significantly increase chances of survival, research shows

Fast diagnosis and treatment can significantly increase chances of survival for melanoma patients, research shows.

One in every three cancers diagnosed is a skin cancer, and melanoma rates are on the rise with 132,000 cases globally each year, according to the World Health Organization.

Researchers from Cleveland Clinic in the US found that a four-month delay in treatment can increase mortality rates by around 40% compared with patients treated within one month.

The research indicates that the sooner patients are treated the better their chance of survival, particularly for stage 1 melanoma.

Game changer

Using the US National Cancer Database, the Cleveland Clinic team studied 153,218 adult patients diagnosed with stages 1 to 3 melanoma from 2004 to 2012.

They found overall survival decreased in patients waiting longer than 90 days for surgical treatment, regardless of stage. In


Want to read more?

Unlock full access to RCNi Plus today

Save over 50% on your first 3 months

  • Customisable clinical dashboard featuring more than 200 topics
  • Unlimited online access to all 10 RCNi Journals and their archives
  • RCNi Learning featuring 180 CPD-accredited learning modules
  • NMC-compliant RCNi Portfolio to build evidence for revalidation
  • Personalised newsletters tailored to your interests

This article is not available as part of an institutional subscription. Why is this?